FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease

Most people with sickle cell disease who received a new gene editing treatment saw their pain resolve for at least one year, but longer follow up is needed

SINSIN
Dec 9, 2023 - 04:00
 0  3
FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease

Most people with sickle cell disease who received a new gene editing treatment saw their pain resolve for at least one year, but longer follow up is needed

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

SIN ScienceX Information Network (SIN) | ScienceX Innovations